UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cellular and molecular imaging of CAR-T cell-based immunotherapy

Advanced drug delivery reviews, 2023-12, Vol.203, p.115135-115135, Article 115135

2023

Volltextzugriff (PDF)

CAR-T Cell Therapy: From the Shop to Cancer Therapy

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15688

2023

Volltextzugriff (PDF)

Current State of the Art of Allogeneic CAR Approaches – Pile ‘Em High and Sell ’Em Cheap

Journal of pharmaceutical sciences, 2021-05, Vol.110 (5), p.1909-1914

Theoharis, Stefanos

2021

Volltextzugriff (PDF)

Charting new paradigms for CAR-T cell therapy beyond current Achilles heels

Frontiers in immunology, 2024-05, Vol.15, p.1409021

2024

Volltextzugriff (PDF)

Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment

EBioMedicine, 2024-08, Vol.106, p.105266, Article 105266

2024

Volltextzugriff (PDF)

In vivo engineering chimeric antigen receptor immune cells with emerging nanotechnologies

Nano today, 2024-12, Vol.59, p.102517, Article 102517

2024

Volltextzugriff (PDF)

In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes

Molecular therapy, 2020-08, Vol.28 (8), p.1783-1794

2020

Volltextzugriff (PDF)

Harmonizing the symphony of chimeric antigen receptor T cell immunotherapy with the elegance of biomaterials

Trends in biotechnology (Regular ed.), 2024-08

2024

Volltextzugriff (PDF)

Large-scale multiplexed mosaic CRISPR perturbation in the whole organism

Cell, 2022-08, Vol.185 (16), p.3008-3024.e16

2022

Volltextzugriff (PDF)

Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy

Immunity (Cambridge, Mass.), 2020-08, Vol.53 (2), p.456-470.e6

2020

Volltextzugriff (PDF)

Impact of Manufacturing Procedures on CAR T Cell Functionality

Frontiers in immunology, 2022-04, Vol.13, p.876339

2022

Volltextzugriff (PDF)

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies

Cancers, 2020-07, Vol.12 (7), p.1915

2020

Volltextzugriff (PDF)

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo

Cancers, 2020-02, Vol.12 (3), p.567

2020

Volltextzugriff (PDF)

Cellular therapy for acute myeloid Leukemia – Current status and future prospects

Blood reviews, 2019-09, Vol.37, p.100578-100578, Article 100578

2019

Volltextzugriff (PDF)

In vivo generated human CAR T cells eradicate tumor cells

Oncoimmunology, 2019-12, Vol.8 (12), p.e1671761-e1671761

2019

Volltextzugriff (PDF)

Characterization of Type IV Carboxylate Reductases (CARs) for Whole Cell‐Mediated Preparation of 3‐Hydroxytyrosol

ChemCatChem, 2019-08, Vol.11 (16), p.4171-4181

2019

Volltextzugriff (PDF)

Imaging CAR T-cell kinetics in solid tumors: Translational implications

Molecular therapy. Oncolytics, 2021-09, Vol.22, p.355-367

2021

Volltextzugriff (PDF)

Development of TaqMan-based real-time PCR based on ψ gene for quantitative detection of CAR-T cells

Analytical biochemistry, 2024-11, Vol.694, p.115626, Article 115626

2024

Volltextzugriff (PDF)

Gene therapy process change evaluation framework: Transient transfection and stable producer cell line comparison

Biochemical engineering journal, 2021-12, Vol.176, p.108202, Article 108202

2021

Volltextzugriff (PDF)

Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma

Frontiers in immunology, 2024-09, Vol.15, p.1328368

2024

Volltextzugriff (PDF)

In vivo manufacture and manipulation of CAR-T cells for better druggability

Cancer and metastasis reviews, 2024-09, Vol.43 (3), p.1075-1093

2024

Volltextzugriff (PDF)

To enhance the ex vivo expansion of CAR-NK-92 cells by regulating intracellular redox status

Process biochemistry (1991), 2024-11, Vol.146, p.355-363

2024

Volltextzugriff (PDF)

Co‐expression of IL‐7 and PH20 promote anti‐GPC3 CAR‐T tumour suppressor activity in vivo and in vitro

Liver international, 2021-05, Vol.41 (5), p.1033-1043

2021

Volltextzugriff (PDF)

Endogenous Signaling Molecule Activating (ESMA) CARs: A Novel CAR Design Showing a Favorable Risk to Potency Ratio for the Treatment of Triple Negative Breast Cancer

International journal of molecular sciences, 2024-01, Vol.25 (1), p.615

2024

Volltextzugriff (PDF)

Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling

Advanced materials (Weinheim), 2024-05, Vol.36 (19), p.e2308377

2024

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Cellular and molecular imaging of CAR-T cell-based immunotherapy

CAR-T Cell Therapy: From the Shop to Cancer Therapy

Current State of the Art of Allogeneic CAR Approaches – Pile ‘Em High and Sell ’Em Cheap

Charting new paradigms for CAR-T cell therapy beyond current Achilles heels

Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment

In vivo engineering chimeric antigen receptor immune cells with emerging nanotechnologies

In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes

Harmonizing the symphony of chimeric antigen receptor T cell immunotherapy with the elegance of biomaterials

Large-scale multiplexed mosaic CRISPR perturbation in the whole organism

Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy

Impact of Manufacturing Procedures on CAR T Cell Functionality

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells In Vivo

Cellular therapy for acute myeloid Leukemia – Current status and future prospects

In vivo generated human CAR T cells eradicate tumor cells

Characterization of Type IV Carboxylate Reductases (CARs) for Whole Cell‐Mediated Preparation of 3‐Hydroxytyrosol

Imaging CAR T-cell kinetics in solid tumors: Translational implications

Development of TaqMan-based real-time PCR based on ψ gene for quantitative detection of CAR-T cells

Gene therapy process change evaluation framework: Transient transfection and stable producer cell line comparison

Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma

In vivo manufacture and manipulation of CAR-T cells for better druggability

To enhance the ex vivo expansion of CAR-NK-92 cells by regulating intracellular redox status

Co‐expression of IL‐7 and PH20 promote anti‐GPC3 CAR‐T tumour suppressor activity in vivo and in vitro

Endogenous Signaling Molecule Activating (ESMA) CARs: A Novel CAR Design Showing a Favorable Risk to Potency Ratio for the Treatment of Triple Negative Breast Cancer

Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling

Suchergebnisse filtern